<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-19T20:00:59Z</responseDate><request verb="GetRecord" identifier="oai:openscholar.dut.ac.za:10321/1987" metadataPrefix="oai_dc">https://openscholar.dut.ac.za/server/oai/request</request><GetRecord><record><header><identifier>oai:openscholar.dut.ac.za:10321/1987</identifier><datestamp>2025-03-07T22:45:15Z</datestamp><setSpec>com_10321_11</setSpec><setSpec>col_10321_12</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>A 'family group analysis' (Sankaran)  evaluation of a triple-blind homoeopathic  drug proving of Erythrina Lysistemon 30CH</dc:title>
   <dc:creator>De Beer, Estelle</dc:creator>
   <dc:contributor>Ross, Ashley Hilton Adrian</dc:contributor>
   <dc:subject>Homeopathy</dc:subject>
   <dc:description>Dissertation submitted in partial compliance with the requirements for the Master's Degree in Technology: Homeopathy, Durban University of Technology, Durban, South Africa, 2007.</dc:description>
   <dc:description>The aim of this analytical study was to determine the effects of the thirtieth  centesimal (30CH) potency of the bark of Erythrina Lysistemon on healthy  individuals with the subsequent analysis of the proving data obtained according  to Sankaran's model! theory of vital sensations and miasms, so that it may be  prescribed according to the Law of Similars, as required by homoeopathic  science.  Thirty-two healthy volunteers who met all the inclusion criteria participated in this  study (Appendix A - Suitability for Inclusion). All volunteers were required to sign  a consent form (Appendix B). Forty (40) percent (12 of the 32) of the subjects  received placebo in a randomised fashion. This was a triple-blind, placebo  controlled study where neither the researchers nor the individuals participating in  the study knew who received placebo or verum. The provers were unaware of  the nature of the substance they were taking and the researchers were unaware  of the nature of the substance that they were administrating. The provers  recorded their state prior to the administration of the proving substance to  establish a baseline from which their state after taking the proving substance was  compared (Appendix D - Instructions to Provers).  Data collection took the format of a diary or journal in which the provers recorded  their symptoms daily and from which the data was later extracted. Data from</dc:description>
   <dc:description>M</dc:description>
   <dc:date>2017-01-31T06:47:25Z</dc:date>
   <dc:date>2017-01-31T06:47:25Z</dc:date>
   <dc:date>2007</dc:date>
   <dc:type>Thesis</dc:type>
   <dc:identifier>http://hdl.handle.net/10321/1987</dc:identifier>
   <dc:identifier>https://doi.org/10.51415/10321/1987</dc:identifier>
   <dc:language>en</dc:language>
   <dc:format>227 p</dc:format>
   <dc:format>application/pdf</dc:format>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>